C

Cooper Companies Inc
BMV:COO

Watchlist Manager
Cooper Companies Inc
BMV:COO
Watchlist
Price: 1 221 MXN Market Closed
Market Cap: Mex$12.8B

P/OCF

0.8
Current
39%
Cheaper
vs 3-y average of 1.4

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
0.8
=
Market Cap
Mex$13.1B
/
Operating Cash Flow
$866.4m

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
0.8
=
Market Cap
Mex$13.1B
/
Operating Cash Flow
$866.4m

Valuation Scenarios

Cooper Companies Inc is trading below its 3-year average

If P/OCF returns to its 3-Year Average (1.4), the stock would be worth Mex$2 014.22 (65% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+1 834%
Average Upside
867%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 0.8 Mex$1 221
0%
3-Year Average 1.4 Mex$2 014.22
+65%
5-Year Average 1.4 Mex$2 014.22
+65%
Industry Average 16.1 Mex$23 610.44
+1 834%
Country Average 13.3 Mex$19 600.97
+1 505%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
Market Cap P/OCF P/E
US
Cooper Companies Inc
BMV:COO
12.8B MXN 0.8 1.8
JP
Hoya Corp
TSE:7741
9.9T JPY 39.4 39.6
US
Medline Inc
NASDAQ:MDLN
58.1B USD 0 0
CH
Alcon AG
SIX:ALC
29B CHF 16 37.1
DK
Coloplast A/S
CSE:COLO B
91B DKK 13.5 23.2
US
Align Technology Inc
NASDAQ:ALGN
12.7B USD 21.3 30.8
UK
ConvaTec Group PLC
LSE:CTEC
4.2B GBP 12 32.2
JP
Asahi Intecc Co Ltd
TSE:7747
905.8B JPY 22.4 51.2
CA
Bausch + Lomb Corp
NYSE:BLCO
5.6B USD 19.6 -15.4
KR
HLB Inc
KOSDAQ:028300
8.3T KRW -90 -37.8
CN
Intco Medical Technology Co Ltd
SZSE:300677
37.5B CNY 22.2 22
P/E Multiple
Earnings Growth PEG
US
C
Cooper Companies Inc
BMV:COO
Average P/E: 29.7
1.8
-46%
N/A
JP
Hoya Corp
TSE:7741
39.6
15%
2.6
US
M
Medline Inc
NASDAQ:MDLN
Not Available
30%
N/A
CH
Alcon AG
SIX:ALC
37.1
32%
1.2
DK
Coloplast A/S
CSE:COLO B
23.2
21%
1.1
US
Align Technology Inc
NASDAQ:ALGN
30.8
34%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
32.2
41%
0.8
JP
A
Asahi Intecc Co Ltd
TSE:7747
51.2
40%
1.3
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.4 N/A N/A
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -37.8 N/A N/A
CN
Intco Medical Technology Co Ltd
SZSE:300677
22
12%
1.8

Market Distribution

Lower than 99% of companies in the United States of America
Percentile
1st
Based on 9 488 companies
1st percentile
0.8
Low
0 — 8.8
Typical Range
8.8 — 20.1
High
20.1 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 8.8
Median 13.3
70th Percentile 20.1
Max 3 188 432.5

Cooper Companies Inc
Glance View

In the world of healthcare innovation, Cooper Companies Inc. etched its name as a significant player, specializing in creating products that enhance lives, particularly in the fields of vision care and women’s health. Established in 1958, Cooper Companies evolved to become a holding company operating through its two primary business units: CooperVision and CooperSurgical. CooperVision is renowned globally for its expertise in contact lenses, providing a diversified range of lenses to correct myopia, hyperopia, astigmatism, and presbyopia. By leveraging cutting-edge technology and a deep understanding of wearer needs, CooperVision caters to a wide spectrum of users, from daily disposables to specialty lenses, thus driving consistent revenue through the consumable nature of its products. CooperSurgical, on the other hand, focuses on solutions for women’s health, offering a gamut of medical instruments, devices, and diagnostics. This unit extends Cooper Companies' footprint into the realms of fertility products, contraception, and obstetrics. By addressing key segments of the women’s health market, CooperSurgical supports clinical needs across a woman’s lifespan. Revenue opportunities here arise from both its durable medical equipment and consumable products, which ensure a stream of repeat business as healthcare providers replenish their supplies. Together, these divisions enable Cooper Companies to not only secure a robust market position but also continuously explore new areas for growth and expansion within the broader healthcare industry.

COO Intrinsic Value
5 300.01 MXN
Undervaluation 77%
Intrinsic Value
Price Mex$1 221
C
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett